Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 28Unknown 21Recruiting 14Active not recruiting 6Terminated 5Not yet recruiting 5Withdrawn 3Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Opioid-Related Disorders 1Meningioma 1Lymphoma, Follicular 1Glioma 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Hematologic Tests × Clear all
NCT05251376 2023-01-19

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Lyndra Inc.

Phase 1 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT01838265 2014-12-08

MGM

University of Miami

Withdrawn
Genitourinary

Prostatic Neoplasms

NCT00985036 2012-04-24

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Marquette General Health System

Withdrawn
CNS

Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡